These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 12088160

  • 1. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
    Thase ME, Rush AJ, Manber R, Kornstein SG, Klein DN, Markowitz JC, Ninan PT, Friedman ES, Dunner DL, Schatzberg AF, Borian FE, Trivedi MH, Keller MB.
    J Clin Psychiatry; 2002 Jun; 63(6):493-500. PubMed ID: 12088160
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT, Rush AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, Trivedi MH, Rothbaum BO, Zajecka J, Borian FE, Keller MB.
    J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
    [Abstract] [Full Text] [Related]

  • 3. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
    Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin, Keller B.
    Sleep; 2003 Mar 15; 26(2):130-6. PubMed ID: 12683470
    [Abstract] [Full Text] [Related]

  • 4. Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
    Zajecka J, Dunner DL, Gelenberg AJ, Hirschfeld RM, Kornstein SG, Ninan PT, Rush AJ, Thase ME, Trivedi MH, Arnow BA, Borian FE, Manber R, Keller MB.
    J Clin Psychiatry; 2002 Aug 15; 63(8):709-16. PubMed ID: 12197452
    [Abstract] [Full Text] [Related]

  • 5. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
    Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, Crits-Christoph P, Keller MB.
    Biol Psychiatry; 2002 Jan 15; 51(2):123-33. PubMed ID: 11822991
    [Abstract] [Full Text] [Related]

  • 6. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB.
    Arch Gen Psychiatry; 2005 May 15; 62(5):513-20. PubMed ID: 15867104
    [Abstract] [Full Text] [Related]

  • 7. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.
    J Clin Psychiatry; 1997 May 15; 58(5):185-92. PubMed ID: 9184611
    [Abstract] [Full Text] [Related]

  • 8. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.
    Kocsis JH, Leon AC, Markowitz JC, Manber R, Arnow B, Klein DN, Thase ME.
    J Clin Psychiatry; 2009 Mar 15; 70(3):354-61. PubMed ID: 19192474
    [Abstract] [Full Text] [Related]

  • 9. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Kocsis JH, Rush AJ, Markowitz JC, Borian FE, Dunner DL, Koran LM, Klein DN, Trivedi MH, Arnow B, Keitner G, Kornstein SG, Keller MB.
    Psychopharmacol Bull; 2003 Mar 15; 37(4):73-87. PubMed ID: 15131518
    [Abstract] [Full Text] [Related]

  • 10. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
    Rush AJ, Trivedi MH, Carmody TJ, Ibrahim HM, Markowitz JC, Keitner GI, Kornstein SG, Arnow B, Klein DN, Manber R, Dunner DL, Gelenberg AJ, Kocsis JH, Nemeroff CB, Fawcett J, Thase ME, Russell JM, Jody DN, Borian FE, Keller MB.
    Neuropsychopharmacology; 2005 Feb 15; 30(2):405-16. PubMed ID: 15578008
    [Abstract] [Full Text] [Related]

  • 11. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
    Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J.
    N Engl J Med; 2000 May 18; 342(20):1462-70. PubMed ID: 10816183
    [Abstract] [Full Text] [Related]

  • 12. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Rickels K, Schweizer E, Case WG, DeMartinis N, Greenblatt DJ, Mandos LA, Garcia España FG.
    J Clin Psychopharmacol; 1998 Apr 18; 18(2):145-53. PubMed ID: 9580369
    [Abstract] [Full Text] [Related]

  • 13. Open trial of nefazodone for combat-related posttraumatic stress disorder.
    Hertzberg MA, Feldman ME, Beckham JC, Moore SD, Davidson JR.
    J Clin Psychiatry; 1998 Sep 18; 59(9):460-4. PubMed ID: 9771816
    [Abstract] [Full Text] [Related]

  • 14. Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
    Manber R, Arnow B, Blasey C, Vivian D, McCullough JP, Blalock JA, Klein DN, Markowitz JC, Riso LP, Rothbaum B, Rush AJ, Thase ME, Keller MB.
    Psychol Med; 2003 May 18; 33(4):693-702. PubMed ID: 12785471
    [Abstract] [Full Text] [Related]

  • 15. The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis.
    Bausch P, Fangmeier T, Zobel I, Schoepf D, Drost S, Schnell K, Walter H, Berger M, Normann C, Schramm E.
    Clin Psychol Psychother; 2017 Sep 18; 24(5):1155-1162. PubMed ID: 28326653
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.
    Arnow BA, Manber R, Blasey C, Klein DN, Blalock JA, Markowitz JC, Rothbaum BO, Rush AJ, Thase ME, Riso LP, Vivian D, McCullough JP, Keller MB.
    J Consult Clin Psychol; 2003 Dec 18; 71(6):1025-35. PubMed ID: 14622078
    [Abstract] [Full Text] [Related]

  • 17. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB.
    Biol Psychiatry; 2003 Oct 15; 54(8):806-17. PubMed ID: 14550680
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.
    J Clin Psychiatry; 1998 May 15; 59(5):246-53. PubMed ID: 9632036
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
    Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel GW, Kaplita SB, Fleming JB, Montplaisir J, Erman MK, Albala BJ, McQuade RD.
    Biol Psychiatry; 1998 Jul 01; 44(1):3-14. PubMed ID: 9646878
    [Abstract] [Full Text] [Related]

  • 20. Which depressed patients respond to nefazodone and when?
    Trivedi MH, Rush AJ, Pan JY, Carmody TJ.
    J Clin Psychiatry; 2001 Mar 01; 62(3):158-63. PubMed ID: 11305700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.